Lam Research Corporation (NASDAQ:LRCX) Shares Purchased by Boston Partners

Boston Partners lifted its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 9,978.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,350,362 shares of the semiconductor company's stock after acquiring an additional 2,327,041 shares during the period. Boston Partners owned 0.18% of Lam Research worth $170,787,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after acquiring an additional 8,364,375 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Lam Research by 950.5% in the fourth quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company's stock worth $2,495,128,000 after acquiring an additional 31,255,726 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Lam Research by 2.8% in the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock worth $1,259,947,000 after acquiring an additional 472,636 shares during the last quarter. Northern Trust Corp lifted its position in Lam Research by 1,067.0% during the fourth quarter. Northern Trust Corp now owns 15,869,244 shares of the semiconductor company's stock worth $1,146,235,000 after buying an additional 14,509,407 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Lam Research by 6,383.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company's stock worth $980,500,000 after buying an additional 13,365,317 shares in the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Price Performance

LRCX stock opened at $106.74 on Thursday. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $135.09 billion, a PE ratio of 25.66, a P/E/G ratio of 1.36 and a beta of 1.65. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $107.49. The business's fifty day moving average price is $96.79 and its 200 day moving average price is $83.51.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.12. The firm had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%. The company's quarterly revenue was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.03 EPS. On average, sell-side analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 9th. Shareholders of record on Wednesday, June 18th were issued a dividend of $0.23 per share. The ex-dividend date was Wednesday, June 18th. This represents a $0.92 annualized dividend and a yield of 0.9%. Lam Research's dividend payout ratio is 22.12%.

Wall Street Analyst Weigh In

LRCX has been the topic of a number of analyst reports. Needham & Company LLC lifted their price objective on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Wall Street Zen upgraded Lam Research from a "hold" rating to a "buy" rating in a research report on Saturday, August 2nd. Morgan Stanley lifted their price objective on Lam Research from $87.00 to $94.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Stifel Nicolaus lifted their price objective on Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. Finally, UBS Group lifted their price objective on Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research report on Monday, July 21st. Seven equities research analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. According to data from MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and a consensus target price of $107.09.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.